Sysmex Inostics is working to strengthen its global relationship with pharmaceutical companies in orde...
Liquid biopsies: from here to beyond
Sysmex Inostics Exhibits at Association of Molecular Pathology 2022 Annual Meeting & Expo in Phoe...
Key differences between HPV-positive and HPV-negative head and neck squamous cell carcinomas (HNSCC)
Sysmex Inostics & QIAGEN Highlight Cancer Companion Diagnostics Alliance at ASCO 2022
Sysmex Inostics Expands Blood Test Offerings for Detection of Acute Myeloid Leukemia
Sysmex Inostics Introduces CLIA-Validated Highly Sensitive HNSCC-SEQ Testing Services for Head and Nec...
University of Chicago Clinical Trial Utilizes Sysmex Inostics Highly Effective HPV-SEQ Test to Measure...
New Ultra-Sensitive Leukemia Blood Test Delivered by Sysmex Inostics
